UPDATE 1-AstraZeneca names Dunoyer new CFO as drug sales, profits drop
October 31, 2013 at 03:43 AM EDT
LONDON, Oct 31 (Reuters) - AstraZeneca promoted Marc Dunoyer to be its new chief financial officer on Thursday, plugging a gap in the British drugmaker's top management team as it grapples with falling sales and profits.
